SHASUN PHARMACEUTICALS LTD. - Outcome of Board Meeting

	< Back
08 Jun 2015
Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2015, has approved the conversion of 71,00,000 convertible warrants into equity shares of the Company, which were issued on May 30, 2014 to M/s. Sequent Scientific Limited, Mumbai, on preferential basis at a price of Rs 110 per share including premium of Rs 108 per share.
View all announcements for SHASUN PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us